PIRS - Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03 revenue of $3.7M misses by $6.77M
- Pieris Pharmaceuticals press release ( NASDAQ: PIRS ): Q2 GAAP EPS of -$0.14 misses by $0.03 .
- Revenue of $3.7M (+12.5% Y/Y) misses by $6.77M .
- Cash, equivalents, and investments totaled $80.9 million for the quarter ended June 30, 2022, compared to a cash and cash equivalents balance of $117.8 million for the quarter ended December 31, 2021..
- Shares +4.95% PM.
For further details see:
Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03, revenue of $3.7M misses by $6.77M